This topic contains a solution. Click here to go to the answer

Author Question: A patient is about to begin treatment for latent tuberculosis with a short course of daily rifampin. ... (Read 63 times)

jlmhmf

  • Hero Member
  • *****
  • Posts: 552
A patient is about to begin treatment for latent tuberculosis with a short course of daily rifampin. The patient asks why rifapentine (Priftin) cannot be used, because it can be given twice weekly.
 
  What will the nurse tell this patient about rifapentine?
  a. It is more toxic than rifampin.
  b. It is not approved for treatment of latent TB.
  c. It is not well absorbed and thus not as effective.
  d. It will stain contact lenses orange.

Question 2

A patient who is being treated for HIV infection has a 5-mm area of induration after a routine TST. The patient's chest radiograph is normal, and there are no other physical findings. The nurse will expect this patient to begin treatment with which drugs?
 
  a. Isoniazid and rifabutin
  b. Isoniazid and rifampin
  c. Isoniazid and rifapentine
  d. Isoniazid and pyrazinamide



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

miss_1456@hotmail.com

  • Sr. Member
  • ****
  • Posts: 289
Answer to Question 1

ANS: B
Rifapentine is indicated only for pulmonary TB. Rifapentine's toxicity is similar to that of rifampin. Rifapentine is well absorbed. Both drugs stain contact lenses.

Answer to Question 2

ANS: A
Rifabutin is used off-label as an alternative to rifampin to treat TB in patients with HIV, because it has less impact on the metabolism of protease inhibitors. The effects of rifapentine on protease inhibitors is similar to those of rifampin. Pyrazinamide is not indicated.




jlmhmf

  • Member
  • Posts: 552
Reply 2 on: Jul 23, 2018
Gracias!


Hdosisshsbshs

  • Member
  • Posts: 315
Reply 3 on: Yesterday
Excellent

 

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

Did you know?

In the United States, congenital cytomegalovirus causes one child to become disabled almost every hour. CMV is the leading preventable viral cause of development disability in newborns. These disabilities include hearing or vision loss, and cerebral palsy.

Did you know?

Over time, chronic hepatitis B virus and hepatitis C virus infections can progress to advanced liver disease, liver failure, and hepatocellular carcinoma. Unlike other forms, more than 80% of hepatitis C infections become chronic and lead to liver disease. When combined with hepatitis B, hepatitis C now accounts for 75% percent of all cases of liver disease around the world. Liver failure caused by hepatitis C is now leading cause of liver transplants in the United States.

Did you know?

Colchicine is a highly poisonous alkaloid originally extracted from a type of saffron plant that is used mainly to treat gout.

Did you know?

Signs and symptoms that may signify an eye tumor include general blurred vision, bulging eye(s), double vision, a sensation of a foreign body in the eye(s), iris defects, limited ability to move the eyelid(s), limited ability to move the eye(s), pain or discomfort in or around the eyes or eyelids, red or pink eyes, white or cloud spots on the eye(s), colored spots on the eyelid(s), swelling around the eyes, swollen eyelid(s), and general vision loss.

For a complete list of videos, visit our video library